Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK.

John J IsittStéphane RozeHelen SharlandGreg CogswellHamza AlshannaqGregory J NormanPeter M Lynch

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

Over patient lifetimes, rt-CGM was associated with improved clinical outcomes and is highly likely to be cost effective versus SMBG in people with T2D on insulin therapy in the UK.

Keyphrases

blood glucose
glycemic control
type diabetes
cross sectional
case report
stem cells
insulin resistance
adipose tissue
skeletal muscle
cell therapy
mesenchymal stem cells
weight loss